Genmab — Maj 2020

[Bulder]

Bib

[Bulder]

Bibob, han har ikke vurderet tallene. Det er konkrete lave IMS-tal, som tyder på tilsvarende lave SH-tal.

[Plimsoller]

God morgen

[bibob]

God morgen.

[bibob]

@ bulder 20.18. Ok, havde overset IMS tal.

[transalp]

Go morgen..

[Helge_LarsenPI-redaktør]

God morgen.

[bongobob]

Morn. Ny forskning. Optimering af ADCC mekanismen. Ny platform? https://www.frontiersin.org/articles/10.3389/fimmu.2020.00740/full

[Sukkeralf]

Tak bongobob

[E_L]

https://twitter.com/DrOlaLandgren/status/1259521252403879936

[E_L]

finans.dk/ https://finans.dk/erhverv/ECE12130169/genmab-naermer-sig-ny-milliardaftale-vi-koerer-mest-aggressivt-frem-med-en-af-aktoererne/?utm_source=dlvr.it&utm_medium=twitter&ctxref=ext

[lahn1]

EL - Nice to see Rajkumar promoting DARA SC

[E_L]

yes. i was however more posting it for this line: NCCN Guidelines 4.2020 for Myeloma have SC added to all regimens containing daratumumab (so that is more broad as in the press release?)

[Sukkeralf]

Yes I also niced that - great

[Solsen]

Kåre Schultz mener covid-19 ændrer på hvorledes man sælger medicin på i fremtiden. Færre kilometer og venten fra sælgernes side. Færre salgsomkostninger. Jf Børsen https://borsen.dk/nyheder/virksomheder/kaare-schultz-covid-19-skaber-varig-forandring. Det set up Genmab har arbejdet på

[Sukkeralf]

Ja godt for ofa og dara

[bibob]

5 C25 aktier over 60 % på styrkebarometer. ØU. https://ugebrev.dk/flashnews/investering/fem-c25-over-60-paa-styrkebarometer-staerkest-er-pandora-71/

[Bulder]

Looks like NCCN guidelines also covers dara in frontline transplant setting, which is not included in the approval message. I have a Q for Winkel about that just to be sure.

[E_L]

good idea!

[E_L]

@bongobob was it not possible to find an easier article to post on a monday morning?? I am wondering if it has anyting to do with Covid-1 research , also since they work together with the Dutch blood bank?